Erratum to: Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations

פריטים דומים

• Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations
  מאת: Nattinger, Ann Butler, et al.
  יצא לאור: (2015)
• Temporal Trends and Regional Variation in the Utilization of Low-Value Breast Cancer Care: Has the Choosing Wisely Campaign Made a Difference?
  מאת: Neuner, Joan, et al.
  יצא לאור: (2019)
• The Introduction of Generic Aromatase Inhibitors and Treatment Adherence Among Medicare D Enrollees
  מאת: Neuner, Joan M., et al.
  יצא לאור: (2015)
• Socioeconomic Disparities in Mortality Among Women With Incident Breast Cancer Before and After Implementation of Medicare Part D
  מאת: Nattinger, Ann B., et al.
  יצא לאור: (2017)
• Quality of Life Among a Population-Based Cohort of Older Patients with Breast Cancer
  מאת: Neuner, Joan M., et al.
  יצא לאור: (2014)